Data on Ocrelizumab treatment collected by MS patients in Germany using Brisa app

Leveraging real-world data from the Brisa app, this study reveals how detailed, patient-reported insights on ocrelizumab treatment can bridge the gap between clinical research and everyday MS care—empowering more personalized, data-driven treatment strategies.

Steffeni Papukchieva, Maria Kahn, Markus Eberl, Benjamin Friedrich, Natalie Joschko,  and Tjalf Ziemssen; Data on Ocrelizumab treatment collected by MS patients in Germany using Brisa app; Journal of Personalized Medicine, 2024, Volume 14, Article 409